Persistence of related bla-IMP-4 metallo-beta-lactamase producing Enterobacteriaceae from clinical and environmental specimens within a burns unit in Australia - a six-year retrospective study

Table 2 Characteristics and outcomes of 7 patients with clinically significant infections

Patient No.	Age and Sex	Co-morbidities	Isolate site (n = 11)	Organism	Treatment	30-day Mortality
1	62 M	Nil	CVC tip	Klebsiella pneumoniae	Amikacin 4 days	Survived
2	61 M	Alcohol abuse	CVC tip	Enterobacter cloacae	Amikacin 14 days	Survived
2	61 M	Alcohol abuse	Blood Sputum	Enterobacter cloacae	Ciprofloxacin 14 days	Survived
3	36 M	Alcohol abuse	Wound	Enterobacter cloacae	Surgical wound debridement, with 1 dose amikacin at time of operation	Survived
4	82 F	COPD, PVD	CVC tip	Enterobacter cloacae	Amikacin 5 days	Survived*
5	62 M	Nil	Wound	Enterobacter cloacae	Amikacin 8 days, ciprofloxacin 7 days	Survived
5	62 M	Nil	Wound	Klebsiella pneumoniae	Amikacin 8 days, ciprofloxacin 7 days	Survived
6	86 F	Nil	Wound	Enterobacter cloacae	Stat dose amikacin, ciprofloxacin 6 days	Survived
7	92 M	Nil known	Blood	Klebsiella pneumoniae	Unknown	Unknown
7	92 M	Nil known	Urine	Klebsiella pneumoniae	Unknown	Unknown

* = died at 34 days after MBL infection, from respiratory failure related to inhalation injury, not attributed to MBL infection.

ISSN: 2047-2994